TNFR2 is required for RIP1-dependent cell death in human leukemia.
Ontology highlight
ABSTRACT: Despite major advances in the treatment of patients with acute lymphoblastic leukemia in the last decades, refractory and/or relapsed disease remains a clinical challenge, and relapsed leukemia patients have an exceedingly dismal prognosis. Dysregulation of apoptotic cell death pathways is a leading cause of drug resistance; thus, alternative cell death mechanisms, such as necroptosis, represent an appealing target for the treatment of high-risk malignancies. We and other investigators have shown that activation of receptor interacting protein kinase 1 (RIP1)-dependent apoptosis and necroptosis by second mitochondria derived activator of caspase mimetics (SMs) is an attractive antileukemic strategy not currently exploited by standard chemotherapy. However, the underlying molecular mechanis
SUBMITTER: Aguade-Gorgorio J
PROVIDER: S-EPMC7556136 | biostudies-literature | 2020 Oct
REPOSITORIES: biostudies-literature
ACCESS DATA